WOUND - Adult Health Nursing
Sources: Bailey & Love's Short Practice of Surgery (28th ed.) | Schwartz's Principles of Surgery (11th ed.) | Sabiston Textbook of Surgery | Pfenninger & Fowler's Procedures for Primary Care (3rd ed.)
1. DEFINITION
A wound is any disruption in the normal continuity of body structures - skin, mucous membrane, or organ tissue - caused by physical, mechanical, chemical, thermal, or pathological processes.
More specifically:
- It is a break in the epithelial integrity of the skin, with or without involvement of deeper structures (dermis, subcutaneous tissue, muscle, bone, viscera)
- Wounds may be intentional (surgical incisions) or unintentional (traumatic injuries)
- A wound that fails to progress through normal healing in an orderly, timely manner is classified as a chronic wound
2. TYPES OF WOUNDS
A. By Mechanism / Etiology
| Type | Description |
|---|
| Incised wound | Clean cut by a sharp instrument (scalpel, knife, glass) |
| Laceration | Irregular tear of tissue by blunt force |
| Contusion | Bruising; intact skin with underlying tissue damage |
| Abrasion | Superficial scraping of skin (epidermis only) |
| Puncture | Deep, narrow wound from a sharp pointed object |
| Avulsion | Forcible tearing away of tissue |
| Crush wound | Tissue compressed between two forces; may have minimal skin break |
| Burn wound | Thermal, chemical, electrical, or radiation injury |
| Bite wound | Human or animal; highly contaminated |
| Degloving | Avulsion of skin and subcutaneous fat from underlying fascia/muscle/bone |
B. By Skin Integrity
| Type | Description |
|---|
| Open wound | Skin or mucosa is broken; tissue exposed to environment |
| Closed wound | Skin intact; damage to underlying tissue (contusion, haematoma) |
C. By Bacterial Contamination (CDC Classification) - Bailey & Love
| Class | Category | Features |
|---|
| I | Clean | Uninfected; no hollow organ entered; primarily closed |
| II | Clean-contaminated | Hollow organ entered under controlled conditions; no infection |
| III | Contaminated | Open fresh accidental wounds; gross GI spillage; acute non-purulent inflammation |
| IV | Dirty | Old wounds with devitalized tissue; existing clinical infection or perforated viscera |
D. By Duration
| Type | Description |
|---|
| Acute wound | Heals in expected time frame (days to weeks) |
| Chronic wound | Fails to heal in orderly/timely manner; stalled in inflammation (>4-6 weeks without progress) |
Chronic wound examples: pressure ulcers, venous leg ulcers, diabetic foot ulcers, arterial ulcers
E. By Depth
- Superficial - epidermis only
- Partial-thickness - epidermis + superficial dermis
- Full-thickness - epidermis + dermis + subcutaneous tissue
- Deep - involves fascia, muscle, tendon, bone, or viscera
3. ETIOLOGY
| Category | Causes |
|---|
| Traumatic | Road traffic accidents, falls, assaults, industrial injuries, bites, gunshot wounds |
| Surgical | Intentional operative incisions |
| Thermal | Burns (heat, cold/frostbite) |
| Chemical | Acids, alkalis, caustic substances |
| Electrical | Electrical current - entry and exit wounds |
| Radiation | Radiation therapy-induced wound breakdown |
| Pathological / Vascular | Arterial insufficiency, venous hypertension (ulcers) |
| Pressure | Sustained pressure over bony prominences causing ischaemic necrosis (pressure ulcers) |
| Diabetic / Neuropathic | Loss of protective sensation + microangiopathy |
| Malignant | Tumour invasion/ulceration through skin |
| Iatrogenic | Extravasation injuries, line-site wounds, post-procedure |
4. CLINICAL MANIFESTATIONS
Local Signs
| Sign | Description |
|---|
| Pain / Tenderness | Variable depending on wound depth and nerve involvement; absent in neuropathic wounds |
| Bleeding / Haemorrhage | Active in acute wounds; may be occult in closed wounds |
| Tissue disruption | Visible break, loss of tissue continuity, exposed structures |
| Swelling / Oedema | Localised, due to inflammatory response |
| Erythema | Redness around wound margin (normal up to 0.5-1 cm); >2 cm suggests infection |
| Warmth (Calor) | Local heat due to increased vascularity |
| Exudate / Discharge | Serous (clear, normal), sanguineous (bloody), serosanguineous (pink), purulent (infection) |
| Odour | Malodour suggests infection or necrosis (Pseudomonas - fruity; anaerobes - fetid) |
| Skin discoloration | Bruising (ecchymosis) in closed injuries; necrosis (black/brown eschar) in severe wounds |
| Wound bed appearance | Red (granulating), yellow (slough), black (necrotic) |
Signs of Wound Infection (NERDS/STONEES Criteria)
Superficial infection (NERDS):
- N - Non-healing wound
- E - Exudate increasing
- R - Red/bleeding wound bed
- D - Debris (slough/tissue) on wound
- S - Smell/odour from wound
Deep infection (STONEES):
- S - Size increasing
- T - Temperature elevated (local and systemic)
- O - Os (bone) exposed
- N - New areas of breakdown
- E - Erythema/oedema
- E - Exudate (purulent)
- S - Smell
Systemic Manifestations (if infected)
- Fever (>38°C), chills, rigors
- Tachycardia, tachypnoea
- Elevated WBC (leukocytosis)
- Fatigue, malaise
- Sepsis/septic shock in severe cases
5. PATHOPHYSIOLOGY
Normal Wound Healing - Four Overlapping Phases
(Schwartz's Principles of Surgery, Sabiston Textbook of Surgery)
Cell sequence during wound healing: neutrophils peak Day 2, macrophages Day 3, lymphocytes Day 7, fibroblasts throughout proliferative phase (Sabiston Textbook of Surgery)
Phase 1: Hemostasis (0 - Hours)
- Tissue injury → vasoconstriction → platelet aggregation and degranulation
- Platelets release: PDGF, TGF-β, VEGF, fibronectin, serotonin
- Coagulation cascade activated → fibrin clot formed
- Fibrin clot = physical barrier to blood loss AND scaffold for healing cells
Phase 2: Inflammation (Hours - Day 4)
- Vasodilation and increased vascular permeability
- Classic signs: Rubor (red), Tumor (swelling), Calor (heat), Dolor (pain)
- Neutrophils (PMNs): First responders; peak 24-48 hours; phagocytose bacteria and debris; release cytokines (TNF-α, IL-1) and proteases
- Macrophages: Peak 48-96 hours; phagocytosis + regulation of repair; release TGF-β, VEGF, EGF, IGF; essential to coordinated healing
Phase 3: Proliferation (Day 3 - Week 3-4)
- Fibroblasts proliferate and synthesize collagen (type III initially, then type I) and ground substance
- Granulation tissue forms: pink, vascular, granular tissue filling the wound bed
- Angiogenesis: New capillary formation supplies oxygen and nutrients
- Epithelialization: Marginal basal cells migrate across wound surface; begins within 24 hours; complete in <48 hours for closed incisions
- Wound contraction: Myofibroblasts pull wound edges inward (prominent in secondary intention healing)
- Collagen synthesis requires: oxygen, vitamin C, iron, zinc, protein
Phase 4: Maturation and Remodeling (Weeks - 12 Months)
- Collagen type III → replaced by stronger type I collagen
- Matrix metalloproteinases (MMPs) continuously remodel collagen
- TGF-β controls balance of synthesis vs. degradation
- Scar becomes progressively avascular and acellular
- Tensile strength reaches 50% at 3 weeks, 80% at 3 months - never achieves 100% of unwounded tissue
- Scar remodeling continues 6-12 months
Chronic Wound Pathophysiology
- Persistent inflammation → proteases (MMPs) overwhelm new tissue formation
- Biofilm formation → impairs host defenses
- Ischaemia/hypoxia → cells cannot sustain proliferation
- Healing remains "stuck" in inflammatory phase
6. DIAGNOSTIC MEASURES
Laboratory
| Test | Purpose |
|---|
| CBC (Complete Blood Count) | WBC elevated in infection; Hgb/Hct for blood loss |
| Blood glucose / HbA1c | Identify diabetes as underlying factor |
| Serum albumin / Pre-albumin | Nutritional status; low albumin impairs healing |
| Coagulation studies (PT, aPTT) | Assess bleeding tendency |
| CRP / ESR / Procalcitonin | Markers of systemic infection/inflammation |
| Blood cultures | If systemic sepsis suspected |
| Wound swab / culture and sensitivity | Identify causative organism; guide antibiotic therapy - surface swab (Levine technique) or tissue biopsy (gold standard: >10^5 organisms/g tissue = infection) |
| Bone biopsy | If osteomyelitis suspected |
Imaging
| Study | Indication |
|---|
| X-ray | Foreign body detection, underlying fracture, osteomyelitis (late changes) |
| Ultrasound | Fluid collections, abscess, vascular insufficiency (Doppler) |
| CT scan | Deep infection, necrotizing fasciitis, foreign bodies, complex wounds |
| MRI | Osteomyelitis (most sensitive), soft tissue extent |
| Ankle-Brachial Index (ABI) | Assess arterial perfusion in leg wounds (ABI <0.8 = arterial insufficiency) |
| Duplex ultrasound | Venous or arterial disease assessment |
Wound-Specific Assessment Tools
| Tool | Use |
|---|
| Wound measurement | Length × width × depth; undermining/tunneling |
| Wound photography | Serial photos to document progress |
| PUSH Tool | Pressure Ulcer Scale for Healing |
| Bates-Jensen Wound Assessment Tool (BWAT) | Comprehensive chronic wound scoring |
| Ankle-Brachial Index | Leg wound vascular assessment |
7. COMPLICATIONS
| Complication | Description |
|---|
| Wound infection / Surgical Site Infection (SSI) | Most common; superficial, deep, or organ/space |
| Wound dehiscence | Partial or complete disruption of wound edges; risk factors: infection, obesity, diabetes, malnutrition, poor suturing technique |
| Evisceration | Extrusion of abdominal contents through dehisced wound; surgical emergency |
| Haematoma | Collection of blood in wound; risk of infection, pressure necrosis |
| Seroma | Collection of serous fluid; impairs healing, risk of infection |
| Abscess formation | Loculated pus requiring drainage |
| Fistula formation | Abnormal tract between wound and another epithelial surface |
| Necrotizing fasciitis | Rapidly spreading infection of fascia/subcutaneous tissue; life-threatening |
| Gas gangrene (Clostridial myonecrosis) | Clostridium perfringens; crepitus, severe pain, systemic toxicity |
| Hypertrophic scar | Raised scar within original wound boundary; may regress |
| Keloid | Raised scar extending beyond original wound; does not regress; more common in dark skin |
| Contracture | Scar shortening across joints → limits range of motion |
| Chronic non-healing wound | Stalled healing >4-6 weeks |
| Malignant transformation | Marjolin's ulcer - SCC developing in chronic wound/scar |
| Osteomyelitis | Bone infection from chronic or deep wound |
| Sepsis / Septic shock | Systemic infection spread; life-threatening |
| Tetanus | From tetanus-prone wounds in non-immunized patients |
8. PROGNOSIS
Prognosis depends on multiple factors:
| Factor | Impact |
|---|
| Wound type/size | Small, clean wounds heal quickly; large/complex wounds take longer |
| Blood supply | Adequate perfusion essential; ischaemic wounds heal poorly |
| Age | Elderly patients have delayed healing |
| Diabetes mellitus | Significantly impairs healing; high risk of amputation |
| Infection | Delays healing; if systemic, worsens overall prognosis |
| Nutrition | Protein and micronutrient deficiency impairs all phases |
| Immunosuppression | Chemotherapy, steroids, HIV increase infection risk |
| Smoking | Reduces tissue oxygenation; delays healing 40-50% |
| Radiation | Impairs vascularity permanently |
| Patient compliance | Adherence to dressing changes, offloading, glucose control |
General prognosis:
- Simple acute wounds in healthy adults: heal well within 2-4 weeks
- Chronic wounds (venous ulcers): 40-70% healed at 24 weeks with optimal care
- Diabetic foot ulcers: 5-year recurrence rate >50%
- Infected wounds with sepsis: mortality increases significantly (septic shock mortality 20-40%)
9. MANAGEMENT
A. MEDICAL MANAGEMENT
1. Wound Irrigation and Cleaning
- Warm normal saline is the standard irrigant
- High-pressure irrigation (20 mL syringe, 19G needle) for contaminated wounds
- Antiseptic solutions (Betadine, chlorhexidine) used with caution - cytotoxic to healing cells at full strength
2. Debridement (Bailey & Love, 28th ed.)
| Method | Description |
|---|
| Surgical | Scalpel/scissors excision of non-viable tissue until healthy bleeding; gold standard |
| Mechanical | Wet-to-dry dressings, irrigation, hydrotherapy; non-selective |
| Autolytic | Hydrocolloid/hydrogel dressings - wound enzymes liquefy necrotic tissue; selective, painless |
| Enzymatic | Topical collagenase or papain-urea; chemically liquefies necrotic tissue |
| Biological (Larval therapy) | Medical-grade maggots of Lucilia sericata; produce proteolytic and antimicrobial substances |
3. Wound Dressings (Pfenninger & Fowler's)
| Wound Type | Dressing Goal | Recommended Dressing |
|---|
| Incisional/Surgical | Protect, immobilize edges | Steri-Strips, low-adherent dressing, semipermeable film |
| Partial-thickness | Facilitate epithelialization, absorb exudate | Foam, hydrocolloid, antibiotic cream + gauze |
| Full-thickness/Dehisced | Maintain moisture, absorb, debride | Hydrogel, alginate, foam, NPWT (VAC) |
| Heavy necrotic load | Debridement, absorb | Larval therapy, VAC dressing |
| Malignant wound | Moisture, odour control | Foam, metronidazole gel, activated charcoal dressing |
Moist wound healing principle: A moist wound environment promotes faster epithelialization and reduces pain (vs. dry dressings)
4. Pharmacological Treatment
| Agent | Indication / Use |
|---|
| Antibiotics | Systemic for cellulitis/deep infection; topical for surface colonization |
| Tetanus prophylaxis | All tetanus-prone wounds (see tetanus table) |
| Analgesics | Pain control; important before dressing changes |
| NSAIDs | Reduce inflammation and fever |
| Corticosteroids | AVOID in acute wounds (impair healing); used in keloid management |
| Vitamin C | Cofactor for collagen synthesis; supplement if deficient |
| Zinc | Cofactor for healing; supplement if deficient |
| Insulin / Glycaemic control | Diabetic wounds - target HbA1c <7% |
| Anticoagulants | Prevent DVT in immobile/post-op patients with wounds |
5. Advanced Medical Therapies
| Therapy | Mechanism |
|---|
| Negative-Pressure Wound Therapy (NPWT/VAC) | Sub-atmospheric pressure draws wound edges together, removes exudate, reduces oedema, promotes granulation tissue |
| Hyperbaric Oxygen Therapy (HBO) | Increases tissue PO2; promotes angiogenesis and collagen synthesis; used for diabetic foot ulcers, radiation wounds, osteomyelitis |
| Biological/Growth factor therapy | Becaplermin (PDGF) gel for diabetic neuropathic ulcers |
| Skin substitutes | Bioengineered skin for large or non-healing wounds |
B. SURGICAL MANAGEMENT
PRE-OPERATIVE ORDERS
PHYSICIAN'S ORDERS - PRE-OPERATIVE
Patient Name: _______________ Date: ____________ Time: ______
Diagnosis: Wound requiring surgical intervention
Procedure: Wound debridement / Wound exploration / Wound closure / Skin graft
1. NOTHING BY MOUTH (NPO)
- NPO after midnight (or 6 hours before procedure for solids,
2 hours for clear liquids per anaesthesia guidelines)
2. LABORATORY INVESTIGATIONS
- CBC with differential
- BMP (Basic Metabolic Panel): BUN, Creatinine, Electrolytes
- Fasting blood glucose / HbA1c (if diabetic)
- PT / INR / aPTT
- Blood group and crossmatch / type and screen
- Serum albumin / Pre-albumin
- Blood cultures x2 (if signs of systemic infection)
- Wound swab for C&S
3. IMAGING
- X-ray of affected area (if foreign body or fracture suspected)
- Doppler ultrasound (if vascular compromise suspected)
4. IV ACCESS
- Insert peripheral IV line (18G or 16G)
- IV fluids: Lactated Ringer's / Normal Saline 0.9% at
___ mL/hr (maintenance rate)
5. MEDICATIONS
- Antibiotic prophylaxis: Cefazolin 2g IV 30-60 minutes
before incision (adjust dose: 3g if weight >120 kg)
- (If penicillin allergy: Clindamycin 900 mg IV OR
Vancomycin 15-20 mg/kg IV)
- Continue home medications EXCEPT:
• Hold anticoagulants (as per physician order)
• Hold metformin 24-48 hours pre-op
• Hold ACE inhibitors / ARBs on day of surgery
6. TETANUS PROPHYLAXIS
- Review immunisation status
- Tetanus toxoid 0.5 mL IM if indicated
- Tetanus immunoglobulin (TIG) 250 IU IM if high-risk wound
and incomplete immunisation
7. ANAESTHESIA CONSULT
- Anaesthesiology review required
8. SKIN PREPARATION
- Clip hair (do not shave) in operative field as needed
- Do NOT apply skin prep until in OR
9. CONSENT
- Informed consent obtained and signed
10. PRE-OP CHECKLIST
- Allergy identification band applied
- Surgical site marked by surgeon
- Remove jewellery, nail polish, prosthetics
- Patient identification confirmed x2 (name + DOB)
Physician Signature: _____________ Time: ______
SURGICAL (OPERATIVE) NOTE
OPERATIVE / SURGICAL NOTE
Date: ____________ Time of procedure: _______ to _______
Surgeon: _______________ Assistant: _______________
Anaesthesiologist: _______________
Anaesthesia type: [ ] General [ ] Regional [ ] Local [ ] MAC
PATIENT: _______________ DOB: _______________
MRN: _______________
PRE-OPERATIVE DIAGNOSIS:
Wound: [specify type, location, size, classification]
e.g., Contaminated traumatic wound, right forearm, 8 x 3 cm
Full-thickness; devitalized tissue; no vascular compromise
POST-OPERATIVE DIAGNOSIS:
[Same / or revised findings]
PROCEDURE PERFORMED:
e.g., Wound exploration, debridement, and primary closure
/ Split-thickness skin graft / Flap coverage
ESTIMATED BLOOD LOSS (EBL): ___ mL
FLUIDS ADMINISTERED: ___ mL (type: ___)
URINE OUTPUT: ___ mL
SPECIMEN SENT: [ ] Wound culture [ ] Tissue biopsy [ ] None
PROCEDURE IN DETAIL:
- Patient positioned: _______________
- Surgical site prepped with ___ (e.g., 2% chlorhexidine
in 70% isopropyl alcohol) and draped in sterile fashion
- Tourniquet applied at ___ mmHg / not used
- Wound explored: extent of injury - [describe layers
involved: dermis / subcutaneous / fascia / muscle /
tendon / bone; neurovascular status]
- Non-viable tissue identified: [colour, texture, amount]
- Debridement performed: [surgical excision of ___ cm²
of devitalized tissue until healthy bleeding margins
obtained]
- Wound irrigated with [saline/betadine] x ___ litres
under pressure
- Haemostasis achieved: [electrocautery / ligation /
pressure]
- Repair of structures: [tendons, vessels, nerves if
applicable]
- Wound closed: [primary / secondary / tertiary intention]
- Deep layers: Vicryl [size] interrupted sutures
- Subcutaneous: Vicryl [size]
- Skin: [nylon / staples / Steri-Strips / skin glue]
- Drain placed: [ ] Yes - type ___ at ___ location
[ ] No
- Dressing applied: [specify type]
- Tourniquet released; circulation confirmed distal to wound
COMPLICATIONS: None / [list if any]
PATIENT CONDITION: Stable / [note any concerns]
PLAN: [Post-op wound care, follow-up, further procedures]
Surgeon Signature: _______________ Date: _______________
POST-OPERATIVE ORDERS
PHYSICIAN'S ORDERS - POST-OPERATIVE
Patient Name: _______________ Date: ____________ Time: ______
Procedure Performed: _______________
Post-op Diagnosis: _______________
1. VITAL SIGNS
- Every 15 minutes x 4, then every 30 min x 2, then
every 1 hour x 4, then every 4 hours (or per unit
protocol)
- Notify physician if:
• Temperature > 38.5°C or < 36°C
• HR > 100 or < 60 bpm
• SBP > 160 or < 90 mmHg
• SpO2 < 94%
• Increasing pain / wound drainage
2. MONITORING
- Continuous cardiac/SpO2 monitoring until stable
- Intake and output every 4 hours
- Blood glucose monitoring every 4-6 hours
(especially if diabetic)
3. ACTIVITY
- Bed rest for ___ hours post-op
- Elevate affected limb above heart level (if applicable)
- Ambulate when fully recovered from anaesthesia
(with assistance x first time)
- No weight bearing on ___ extremity until further
assessment
4. DIET
- Clear liquids when fully awake and bowel sounds present
- Advance to regular diet as tolerated
- High-protein diet encouraged to promote wound healing
5. IV FLUIDS
- Continue IV [NS / LR] at ___ mL/hr
- D/C IV fluids when tolerating oral intake
6. WOUND CARE
- Leave initial dressing intact for 24-48 hours
unless saturated/soiled
- Inspect wound every shift: note colour, temperature,
exudate type and amount, odour, surrounding skin
- First dressing change: _____ (date/time) by surgeon/
nurse per protocol
- Wound care orders: [specify dressing type, frequency]
- NPWT settings if applicable: ___ mmHg continuous/
intermittent
- Drain care: measure output every shift; document colour
and character
- Remove drain when output < 30 mL/24 hours (or per
surgeon order)
7. MEDICATIONS
a. Pain Management:
- Morphine / Hydromorphone PCA: [dose/lockout settings]
OR
- Ketorolac 15-30 mg IV every 6 hours x 5 doses, then
- Paracetamol (Acetaminophen) 1 g IV/oral every 6 hours
- Ibuprofen 400 mg oral every 8 hours with food
b. Antibiotics:
- Continue Cefazolin 1g IV every 8 hours x [24-48 hours
for prophylaxis] OR [5-7 days for established infection]
- (Adjust based on culture and sensitivity results)
c. DVT Prophylaxis:
- Enoxaparin 40 mg SC every 24 hours (start 12-24 hrs
post-op when haemostasis confirmed)
AND
- Sequential Compression Device (SCD) to lower
extremities while in bed
d. GI Protection:
- Omeprazole 20 mg oral/IV daily (while on NSAIDs or
stressed patient)
e. Anti-emetics:
- Ondansetron 4 mg IV every 6 hours PRN nausea
f. Glycaemic Control:
- Target blood glucose 140-180 mg/dL
- Insulin sliding scale / basal-bolus insulin as ordered
g. Nutritional Supplements:
- Vitamin C 500 mg oral twice daily
- Zinc sulfate 220 mg oral daily (if deficient)
- Ensure/Boost supplement with meals if intake inadequate
8. SUTURE / STAPLE REMOVAL
- Facial wounds: Day 5-7
- Scalp: Day 7-10
- Trunk / extremities: Day 10-14
- Over joints: Day 14
- Contaminated/complex wounds: per surgeon review
9. FOLLOW-UP
- Wound clinic/outpatient review in ___ days
- Remove drain on Day ___
- Physiotherapy referral if joint/function involved
- Occupational therapy if hand/upper limb involved
10. DOCUMENTATION
- Document wound assessment each shift
- Photograph wound at baseline and with each major change
- Report signs of infection, dehiscence, or unusual
drainage to physician immediately
Physician Signature: _______________ Time: ______
10. NURSING MANAGEMENT
A. NURSING ASSESSMENT
1. Health History
- Mechanism and time of injury (hours since wound occurred)
- Previous wounds, surgeries, or skin conditions
- Tetanus immunisation status
- Allergies (especially to antiseptics, adhesives, latex)
- Current medications (steroids, anticoagulants, immunosuppressants)
- Past medical history: diabetes, vascular disease, connective tissue disorders, malignancy
- Smoking, alcohol, and nutritional status
- Psychosocial factors: living situation, ability to perform self-care
2. Physical Assessment
Wound-Specific (HEAD-TO-TOE, wound-focused):
| Parameter | What to Assess |
|---|
| Location | Anatomical site; document using body diagram |
| Size | Length × width × depth in centimetres; use ruler/wound measurement guide |
| Wound bed | % Red (granulation), yellow (slough), black (necrosis) |
| Exudate | Amount (none/scant/moderate/heavy), type (serous/sanguineous/serosanguineous/purulent), odour |
| Wound edges | Attached/unattached; rolled/thickened (chronic); undermining/tunneling (measure clock position and depth) |
| Periwound skin | Erythema (measure extent from wound edge), warmth, induration, maceration, excoriation |
| Wound closure | Sutures/staples: intact, approximated, tension-free; signs of dehiscence |
| Drains | Type, position, output volume, character |
| Signs of infection | Increased pain, erythema >2 cm, warmth, purulent drainage, fever |
Systematic Assessment:
- Vital signs (temperature, HR, BP, RR, SpO2)
- Pain assessment: PQRST (Position, Quality, Radiation, Severity 0-10, Time/triggers)
- Neurovascular assessment distal to wound: pulses, capillary refill, sensation, movement
- Nutritional assessment: weight, BMI, dietary intake, albumin level
- Mobility and function: activity level, ability for self-care
- Psychosocial: anxiety, coping, body image concerns
3. Priority Nursing Diagnoses
| Nursing Diagnosis | Related Factors |
|---|
| Impaired tissue integrity | Disruption of skin and tissue continuity |
| Acute/Chronic pain | Tissue damage, inflammation, dressing changes |
| Risk for infection | Break in skin integrity, contamination |
| Impaired physical mobility | Pain, wound location, post-operative restrictions |
| Imbalanced nutrition: less than body requirements | Increased metabolic demands for healing |
| Risk for deficient fluid volume | Blood loss, wound exudate |
| Disturbed body image | Visible wound, scar, disfigurement |
| Knowledge deficit | Wound care, signs of infection, activity restrictions |
| Anxiety | Surgery, wound outcome, disfigurement |
B. NURSING INTERVENTIONS
1. Wound Care
- Perform dressing changes using aseptic/clean technique per hospital protocol
- Irrigate wound with normal saline; use pressure irrigation for contaminated wounds
- Apply appropriate dressing based on wound type and exudate level
- Protect periwound skin from maceration (use skin barrier/zinc oxide)
- Document wound appearance, measurements, and changes each shift
- Photograph wound with patient consent at baseline and regularly
2. Infection Prevention
- Strict hand hygiene before and after wound care
- Maintain sterile/aseptic technique for surgical wounds
- Monitor for SSTI signs every shift; report early indicators promptly
- Administer antibiotics on time; monitor for therapeutic effects
- Teach patient to avoid touching wound; hand hygiene education
3. Pain Management
- Assess pain before, during, and after dressing changes
- Pre-medicate 30-60 minutes before dressing changes (oral analgesia)
- Use non-pharmacological methods: positioning, distraction, relaxation
- Report uncontrolled pain (may indicate wound complication)
4. Nutritional Support
- Collaborate with dietitian for high-protein, high-calorie diet
- Offer protein supplements (Ensure, Boost) if oral intake inadequate
- Ensure adequate vitamin C and zinc intake
- Monitor albumin and pre-albumin levels as healing markers
- Maintain blood glucose <180 mg/dL in diabetic patients
5. Patient and Family Education
| Teaching Topic | Key Points |
|---|
| Wound care | Hand hygiene, dressing change technique, supply procurement |
| Signs of infection | When to call healthcare provider: increasing redness, swelling, purulent discharge, fever, increasing pain |
| Activity restrictions | No straining, lifting >2-5 kg, activity limitations per wound site |
| Diet | High protein, vitamin C-rich foods (citrus, leafy greens), zinc (meat, legumes), adequate hydration |
| Follow-up | Importance of keeping appointments; suture/staple removal timing |
| Scar management | Sunscreen protection, silicone gel, massage after complete closure |
| Medication | Completing antibiotic course, analgesic use |
6. Complications Monitoring and Reporting
| Complication | Nurse Action |
|---|
| Dehiscence | Cover with sterile moist saline dressing; keep patient supine; notify surgeon immediately |
| Evisceration | Medical emergency - cover bowel with large sterile moist saline dressing; keep NPO; call surgeon STAT |
| Haematoma | Monitor size; apply pressure; notify surgeon if expanding |
| Seroma | Monitor; may require aspiration |
| Infection/SSI | Culture wound; intensify cleaning; notify surgeon; antibiotics |
| Sepsis | Activate sepsis protocol: STAT blood cultures, broad-spectrum antibiotics, IV fluids, escalate care |
C. EVALUATION / EXPECTED OUTCOMES
- Wound dimensions decrease progressively (>30% reduction in 4 weeks = positive indicator)
- Wound bed: progressive granulation tissue formation
- Exudate decreasing in amount; no purulent discharge
- No signs of infection (afebrile, WBC normalizing, wound margins non-erythematous)
- Pain well-controlled (VAS/NRS ≤ 3/10)
- Patient and family demonstrate correct wound care technique
- Patient maintains adequate nutritional intake
- Wound completely closed within expected timeframe
Sources: Bailey and Love's Short Practice of Surgery, 28th ed. | Schwartz's Principles of Surgery, 11th ed. | Sabiston Textbook of Surgery, 21st ed. | Pfenninger and Fowler's Procedures for Primary Care, 3rd ed.